Updated 10 August 2026. Regulatory status current as of this date.
Most approved peptide medicines are legal when prescribed appropriately. But wellness and lifestyle peptides such as BPC-157, TB-500 and MOTS-c remain unapproved and unproven; the FDA’s July 2026 advisory vote did not make them approved or immediately legal to compound. UK rules depend partly…
CJC-1295 has one of the strongest published human clinical records of any wellness-market peptide, a Phase 2 trial that was discontinued after a participant death, and a December 2024 FDA advisory committee vote against allowing it into the regulated compounding system. The gap between the science and the regulatory verdict is where its current safety…
BPC-157 is one of the most discussed peptides on the wellness internet and one of the least documented in the human clinical literature, and the gap between those two facts is where most of its safety story sits.
The compound has been studied in laboratories for more than thirty years. It has been studied in…
Zinc sulfide doesn’t show up in everyday health conversations. It doesn’t headline nutrition panels, nor does it make wellness trend forecasts. But behind the scenes, this humble compound is quietly powering a wide range of applications—from phosphorescent materials and optical devices to pigment bases and, in some cases, even skincare.
At first glance, it might…



